Contact this trialFirst, we need to learn more about you.
MAPK Pathway Inhibitor
MRTX0902 + MRTX849 for Solid Tumors
Recruiting1 awardPhase 1 & 2
Denver, Colorado
This trial tests the safety and effectiveness of two cancer drugs to treat advanced tumors with KRAS or MAPK mutations.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.